Table 2.
Laboratory values and early complications in both groups.
| Characteristics | BDC+Chemotherapy | CDC+Chemotherapy | P value |
|---|---|---|---|
| Serum bilirubin level | 0.29# | ||
| Before | 180.5 ± 53.7 | 169.4 ± 16.8 | |
| After | 68.2 ± 20.0 | 64.4 ± 16.8 | |
| P value | 0.00* | 0.00* | |
| Direct bilirubin | 0.64# | ||
| Before | 136.7 ± 46.8 | 135.0 ± 38.4 | |
| After | 42.4 ± 15.0 | 38.4 ± 11.5 | |
| P value | 0.00* | 0.00* | |
| Alanine aminotransferase | 0.22# | ||
| Before | 105.9 ± 44.5 | 91.9 ± 40.6 | |
| After | 49.8 ± 14.0 | 47.4 ± 13.3 | |
| P value | 0.00* | 0.00* | |
| Hemoglobin | 0.36# | ||
| Before | 123.1 ± 18.3 | 127.4 ± 18.0 | |
| After | 125.1 ± 18.4 | 126.6 ± 15.4 | |
| P value | 0.73* | 0.94* | |
| Early complications | 0.43ψ | ||
| Cholangitis | 2 | 4 | |
| Pancreatitis | 1 | 0 | |
| None | 21 | 20 |
*Difference in the values before and after the intervention in the same group (Wilcoxon signed-rank test); #Difference in the variance between the two groups (Mann–Whitney U-test); ψ Fisher’s exact test.